Uses
ChemicalBook > CAS DataBase List > Infigratinib

Infigratinib

Uses
Product Name
Infigratinib
CAS No.
872511-34-7
Chemical Name
Infigratinib
Synonyms
BGJ-398;Infligratinib;BGJ;CS-218;BGJ 398;NVP-BGJ398;Infigratinib;Transcrocetinate;NVP-BGJ398, >=98%;BGJ398 (NVP-BGJ398)
CBNumber
CB52589643
Molecular Formula
C26H31Cl2N7O3
Formula Weight
560.48
MOL File
872511-34-7.mol
More
Less

Infigratinib Property

Melting point:
>211°C (dec.)
Boiling point:
747.9±60.0 °C(Predicted)
Density 
1.354
storage temp. 
-20°C
solubility 
Soluble in DMSO (up to 5 mg/ml)
form 
White solid.
pka
11.02±0.70(Predicted)
color 
White
Stability:
Stable for 1 year from date of purchase as supplied. Solutions in DMSO may be stored at -20°C for up to 2 months.
InChIKey
QADPYRIHXKWUSV-UHFFFAOYSA-N
SMILES
N(C1C=C(NC2=CC=C(N3CCN(CC)CC3)C=C2)N=CN=1)(C)C(NC1=C(Cl)C(OC)=CC(OC)=C1Cl)=O
More
Less

Hazard and Precautionary Statements (GHS)

Symbol(GHS)
Signal word
Warning
Hazard statements

H315Causes skin irritation

H319Causes serious eye irritation

H335May cause respiratory irritation

Precautionary statements

P261Avoid breathing dust/fume/gas/mist/vapours/spray.

P264Wash hands thoroughly after handling.

P264Wash skin thouroughly after handling.

P271Use only outdoors or in a well-ventilated area.

P280Wear protective gloves/protective clothing/eye protection/face protection.

P302+P352IF ON SKIN: wash with plenty of soap and water.

P304+P340IF INHALED: Remove victim to fresh air and Keep at rest in a position comfortable for breathing.

P305+P351+P338IF IN EYES: Rinse cautiously with water for several minutes. Remove contact lenses, if present and easy to do. Continuerinsing.

P312Call a POISON CENTER or doctor/physician if you feel unwell.

P321Specific treatment (see … on this label).

P332+P313IF SKIN irritation occurs: Get medical advice/attention.

P337+P313IF eye irritation persists: Get medical advice/attention.

P362Take off contaminated clothing and wash before reuse.

P403+P233Store in a well-ventilated place. Keep container tightly closed.

P405Store locked up.

P501Dispose of contents/container to..…

More
Less

N-Bromosuccinimide Price

Cayman Chemical
Product number
19157
Product name
BGJ398
Purity
≥98%
Packaging
1mg
Price
$62
Updated
2024/03/01
Cayman Chemical
Product number
19157
Product name
BGJ398
Purity
≥98%
Packaging
5mg
Price
$120
Updated
2024/03/01
Cayman Chemical
Product number
19157
Product name
BGJ398
Purity
≥98%
Packaging
10mg
Price
$191
Updated
2024/03/01
Cayman Chemical
Product number
19157
Product name
BGJ398
Purity
≥98%
Packaging
25mg
Price
$313
Updated
2024/03/01
TRC
Product number
B367000
Product name
BGJ398
Packaging
200mg
Price
$425
Updated
2021/12/16
More
Less

Infigratinib Chemical Properties,Usage,Production

Uses

BGJ 398 is a potent and selective inhibitor of the fibroblast growth factor receptor family of receptor tyrosine kinase.

Description

NVP-BGJ398 (872511-34-7) is a potent and selective pan-FGFR inhibitor (IC50?= 0.9nM, 1.4 nM, 1.0 nM, and 60 nM for FGFR1,2,3,4 respectively).1? It has also been used in a mouse model of Achondroplasia (most common form of dwarfism) to correct pathological hallmarks of this condition.

Uses

BGJ 398 is a potent and selective inhibitor of the fibroblast growth factor receptor family of receptor tyrosine kinase.

Definition

ChEBI: BGJ-398 is a member of the class of phenylureas that is urea in which a hydrogen attached to one of the nitrogens is replaced by a 2,6-dichloro-3,5-dimethoxyphenyl group, while the hydrogens attached to the other nitrogen are replaced by a methyl group and a 6-{[4-(4-ethylpiperazin-1-yl)phenyl]amino}pyrimidin-4-yl group. It is a potent and selective fibroblast growth factor receptor inhibitor. It has a role as a fibroblast growth factor receptor antagonist and an antineoplastic agent. It is an aminopyrimidine, a N-arylpiperazine, a N-alkylpiperazine, a dichlorobenzene and a member of phenylureas.

Indications

Infigratinib is approved by the USFDA for the treatment of previously treated patients with advanced or metastatic cholangiocarcinoma carrying FGFR2 fusion or rearrangement. Its inhibitory effect on FGFR helps reduce the proliferation of tumor cells, especially for cholangiocarcinoma patients with abnormal activation of the FGFR pathway. It is used as an oral drug, which provides convenience for patients.

brand name

Truseltiq

General Description

Class: receptor tyrosine kinase; Treatment: cholangiocarcinoma; Other name: NVP-BGJ398; Elimination half-life = 34 h; Protein binding = 96.8%

Mechanism of action

Infigratinib works at the biochemical and cellular levels by highly selectively inhibiting the activity of FGFR1, FGFR2, FGFR3, and FGFR4. Activation of the FGFR pathway is associated with the proliferation of malignant cancer cells, therefore, inhibition of FGFR-specific kinases can effectively reduce tumor cell proliferation.

Side effects

Side effects of infigratinib may include stomatitis, fatigue, decreased appetite, high blood pressure, and elevated liver enzyme levels.

Synthesis

Infigratinib was synthesized in a modular and polymeric manner by combining three building blocks. Piperidine-substituted aniline 32.4 was prepared by SNAr reaction of piperidine 32.1 and bromonitrobenzene 32.2 at 80°C followed by nitro reduction (Figure 1a). 2,6-Dichloro-3,5-dimethoxyaniline (32.6) was obtained from commercially available 3,5-dimethoxyaniline (32.5) in three steps (acylation, chlorination, and hydrolysis) (Figure 1b), and 6-chloro-N-methylpyrimidin-4-amine (32.8) was prepared by SNAr reaction of dichloropyrimidine 32.7 with methylamine (Figure 1c).

Aniline 32.4 and chloropyrimidine 32.8 were SNAr reacted to generate arylmethylamine 32.9, thereby assembling Infigratinib (Figure 2). The aniline derivative 32.6 was converted in situ to the corresponding isocyanate and combined with 32.9 to form a urea bond, completing the synthesis of Infigratinib.

target

FGFR1

IC 50

FGFR1~4 IC50 = 0.9, 1.4, 1.0, and 60 nM; VEGFR2 IC50 = 180 nM

References

[1] Discovery of 3-(2,6-Dichloro-3,5-dimethoxyphenyl)-1-(6-{[4-(4-ethyl-1-piperazinyl)phenyl]amino}-4-pyrimidinyl)-1-methylurea (NVP-BGJ398), a Potent and Selective Inhibitor of the Fibroblast Growth Factor Receptor Family of Receptor Tyrosine Kinase
[2] DAVIDE KOMLA-EBRI. Tyrosine kinase inhibitor NVP-BGJ398 functionally improves FGFR3-related dwarfism in mouse model.[J]. The Journal of clinical investigation, 2016: 1871-1884. DOI:10.1172/jci83926

Infigratinib Preparation Products And Raw materials

Raw materials

Preparation Products

More
Less

Infigratinib Suppliers

YouCoChem (Beijing) Chemical Technology Co., Ltd.
Tel
18800159827
Email
youcochem@163.com
Country
China
ProdList
162
Advantage
50
Changzhou Yongfeng Biomedicine Co. Ltd.
Tel
15006117673
Fax
2973592490@.com
Email
2973592490@qq.com
Country
China
ProdList
299
Advantage
58
Shanghai YuanQi Biotechnology Co., Ltd.
Tel
+86-2332782371 +86-18120098618
Email
sales@adobechem.com
Country
China
ProdList
1250
Advantage
50
ShangHai Caerulum Pharma Discovery Co., Ltd.
Tel
18149758185
Email
sales-cpd@caerulumpharma.com
Country
China
ProdList
3506
Advantage
58
Shanghai Boyle Chemical Co., Ltd.
Tel
Fax
86-21-57758967
Email
sales@boylechem.com
Country
China
ProdList
2922
Advantage
55
Chembest Research Laboratories Limited
Tel
+86-21-20908456
Fax
021-58180499
Email
sales@BioChemBest.com
Country
China
ProdList
6003
Advantage
61
Jia Xing Isenchem Co.,Ltd
Tel
0573-85285100 18627885956
Fax
0573-85285100
Email
isenchem@163.com
Country
China
ProdList
9310
Advantage
66
Jinan Trio PharmaTech Co., Ltd.
Tel
0531-88811783
Fax
+86 (531) 55696010 QQ 1762738062
Email
sales@trio-pharmatech.com
Country
China
ProdList
1856
Advantage
62
Dalian Meilun Biotech Co., Ltd.
Tel
0411-62910999 13889544652
Email
sales@meilune.com
Country
China
ProdList
4747
Advantage
58
Shanghai Topbiochem Technology Co., Ltd
Tel
021-58170097
Email
info@topbiochem.com
Country
China
ProdList
9510
Advantage
58
More
Less

View Lastest Price from Infigratinib manufacturers

Zibo Hangyu Biotechnology Development Co., Ltd
Product
Infigratinib 872511-34-7
Price
US $0.00/Bag
Min. Order
1Bag
Purity
>99%
Supply Ability
1kg
Release date
2025-06-29
shandong perfect biotechnology co.ltd
Product
Infigratinib (BGJ398) 872511-34-7
Price
US $0.00/g
Min. Order
1g
Purity
98% HPLC
Supply Ability
1kg
Release date
2023-08-02
Career Henan Chemical Co
Product
3-(2,6-Dichloro-3,5-dimethoxyphenyl)-1-[6-[[4-(4-ethylpiperazin-1-yl)phenyl]amino]pyrimidin-4-yl]-1-methylurea 872511-34-7
Price
US $2.00/KG
Min. Order
1g
Purity
98%min
Supply Ability
ask
Release date
2020-01-08

872511-34-7, InfigratinibRelated Search:


  • 3-(2,6-Dichloro-3,5-dimethoxyphenyl)-1-[6-[[4-(4-ethylpiperazin-1-yl)phenyl]amino]pyrimidin-4-yl]-1-methylurea
  • BGJ 398
  • BGJ-398
  • BGJ398 (NVP-BGJ398)
  • NVP-BGJ398
  • 3-(2,6-Dichloro-3,5-dimethoxyphenyl)-1-[6-[[4-(4-ethylpiperazin-1-yl)phenyl]amino]pyrimidin-4-yl]-1-methylurea NVP-BGJ398
  • NVP-BGJ398 3-(2,6-Dichloro-3,5-dimethoxyphenyl)-1-[6-[[4-(4-ethylpiperazin-1-yl)phenyl]amino]pyrimidin-4-yl]-1-methylurea
  • Urea, N'-(2,6-dichloro-3,5-dimethoxyphenyl)-N-[6-[[4-(4-ethyl-1-piperazinyl)phenyl]amino]-4-pyrimidinyl]-N-methyl-, methanesulfonate
  • Urea, N'-(2,6-dichloro-3,5-dimethoxyphenyl)-N-[6-[[4-(4-ethyl-1-piperazinyl)phenyl]amino]-4-pyrimidinyl]-N-methyl-
  • NVP-BGJ398, >=98%
  • NVP-BGJ398 (Infigratinib)
  • CS-218
  • NVP-BGJ398; BGJ398; BGJ-398;INFIGRATINIB;BGJ 398
  • BGJ
  • BGJ-398 phosphate,NVP-BGJ398 phosphate,Infigratinib phosphate
  • Transcrocetinate
  • BGJ398 (NVP-BGJ398);BGJ-398; BGJ 398; NVP BGJ398
  • 3-(2,6-Dichloro-3,5-dimethoxyphenyl)-1-(6-((4-(4-ethylpiperazin-1-yl)phenyl)amino)pyrimidin-4-
  • NVP-BGJ398(BGJ-398,Infigratinib)
  • Infligratinib
  • NVP-BGJ398(BGJ-398)
  • Infigratinib (BGJ-398)
  • Infigratinib free base
  • 3-(2,6-dichloro-3,5-dimethoxyphenyl)-1-[6-[4-(4-ethylpiperazin-1-yl)anilino]pyrimidin-4-yl]-1-methylurea
  • Apoptosis,Infigratinib,Fibroblast growth factor receptor,BGJ398,inhibit,Inhibitor,BGJ 398,FGFR
  • Infigratinib
  • 3-(2,6-Dichloro-3,5-dimethoxyphenyl)-1-[6-[[4-(4-ethyl-1-piperazinyl)phenyl]amino]-4-pyrimidinyl]-1-methylurea
  • Infigratinib, 10 mM in DMSO
  • Infigratinib/BGJ398 (NVP-BGJ398)
  • 872511-34-7
  • 72511-34-7
  • C26H31Cl2N7O3
  • Inhibitors
  • Inhibitor
  • API